Buy Like Buffett
Watchlist

Flagship explainer

How Onconetix, Inc. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$815371 · 100%Cost of revenue$182458 · 22%Gross profit$632913 · 78%Operating income−$17.9M · −2190%Income before tax−$14M · −1721%Income tax$525 · 0%Net income−$14M · −1721%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$815371100%
  • 10-K · FY 2025Filing detailsAccession 0001213900-26-027725 · filed Mar 13, 2026
Cost of revenue$18245822%
  • 10-K · FY 2025Filing detailsAccession 0001213900-26-027725 · filed Mar 13, 2026
$63291378%
  • 10-K · FY 2025Filing detailsAccession 0001213900-26-027725 · filed Mar 13, 2026
−$17.9M−2190%
  • 10-K · FY 2025Filing detailsAccession 0001213900-26-027725 · filed Mar 13, 2026
Income before tax−$14M−1721%
  • 10-K · FY 2025Filing detailsAccession 0001213900-26-027725 · filed Mar 13, 2026
Income tax$5250%
  • 10-K · FY 2025Filing detailsAccession 0001213900-26-027725 · filed Mar 13, 2026
−$14M−1721%
  • 10-K · FY 2025Filing detailsAccession 0001213900-26-027725 · filed Mar 13, 2026
Source:
  • 10-K · FY 2025Filing detailsAccession 0001213900-26-027725 · filed Mar 13, 2026
· event Dec 31, 2025 · retrieved Oct 16, 2026 · annual-row source set
Embed this chart

View the full Onconetix, Inc. analysis at Buy Like Buffett